View:
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
--------------
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported) March 3, 1997
-------------
LABORATORY CORPORATION OF AMERICA HOLDINGS
------------------------------------------
(Exact Name of Registrant as Specified in Charter)
DELAWARE 1-11353 13-3757370
-------------------------------------------------------
(State or other (Commission File (IRS Employer
Jurisdiction of Number) Identification
Incorporation) No.)
358 SOUTH MAIN STREET, BURLINGTON, NORTH CAROLINA 27215
-------------------------------------------------------
(Address of Principal Executive Offices) (Zip Code)
Registrant's telephone number, including area code 910-229-1127
------------
ITEM 7. FINANCIAL STATEMENTS, PRO FORMA FINANCIAL INFORMATION AND EXHIBITS
(c) Exhibit
23 Consent of KPMG Peat Marwick LLP
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
LABORATORY CORPORATION OF AMERICA HOLDINGS
------------------------------------------
(Registrant)
By: /s/Wesley R. Elingburg
----------------------
Wesley R. Elingburg
Executive Vice President,
Chief Financial Officer
and Treasurer
Date: March 3, 1997
EXHIBIT 23
Independent Auditors' Consent
The Board of Directors
Laboratory Corporation of America Holdings:
We consent to the use of our reports incorporated by reference in the National
Health Laboratories Holdings, Inc. Registration Statement on Forms S-4/S-3,
dated April 25, 1995 (Registration No. 33-58775) filed under the Securities
Act of 1933, as amended and to the reference to our firm under the heading
"Experts" in the resale Prospectus.
/s/ KPMG Peat Marwick LLP
Raleigh, North Carolina
March 3, 1997